Training attention control of very preterm infants: protocol for a feasibility study of the Attention Control Training (ACT).

Attention Computerized Cognitive Training Eye-tracking methodology Feasibility study Infant, Premature

Journal

Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536

Informations de publication

Date de publication:
2020
Historique:
received: 12 04 2019
accepted: 27 01 2020
entrez: 15 2 2020
pubmed: 15 2 2020
medline: 15 2 2020
Statut: epublish

Résumé

Children born preterm may display cognitive, learning, and behaviour difficulties as they grow up. In particular, very premature birth (gestation age between 28 and less than 32 weeks) may put infants at increased risk of intellectual deficits and attention deficit disorder. Evidence suggests that the basis of these problems may lie in difficulties in the development of executive functions. One of the earliest executive functions to emerge around 1 year of age is the ability to control attention. An eye-tracking-based cognitive training programme to support this emerging ability, the Attention Control Training (ACT), has been developed and tested with typically developing infants. The aim of this study is to investigate the feasibility of using the ACT with healthy very preterm (VP) infants when they are 12 months of age (corrected age). The ACT has the potential to address the need for supporting emerging cognitive abilities of VP infants with an early intervention, which may capitalise on infants' neural plasticity. The feasibility study is designed to investigate whether it is possible to recruit and retain VP infants and their families in a randomised trial that compares attention and social attention of trained infants against those that are exposed to a control procedure. Feasibility issues include the referral/recruitment pathway, attendance, and engagement with testing and training sessions, completion of tasks, retention in the study, acceptability of outcome measures, quality of data collected (particularly, eye-tracking data). The results of the study will inform the development of a larger randomised trial. Several lines of evidence emphasise the need to support emerging cognitive and learning abilities of preterm infants using early interventions. However, early interventions with preterm infants, and particularly very preterm ones, face difficulties in recruiting and retaining participants. These problems are also augmented by the health vulnerability of this population. This feasibility study will provide the basis for informing the implementation of an early cognitive intervention for very preterm infants. Registered Registration ID: NCT03896490. Retrospectively registered at Clinical Trials Protocol Registration and Results System (clinicaltrials.gov).

Sections du résumé

BACKGROUND BACKGROUND
Children born preterm may display cognitive, learning, and behaviour difficulties as they grow up. In particular, very premature birth (gestation age between 28 and less than 32 weeks) may put infants at increased risk of intellectual deficits and attention deficit disorder. Evidence suggests that the basis of these problems may lie in difficulties in the development of executive functions. One of the earliest executive functions to emerge around 1 year of age is the ability to control attention. An eye-tracking-based cognitive training programme to support this emerging ability, the Attention Control Training (ACT), has been developed and tested with typically developing infants. The aim of this study is to investigate the feasibility of using the ACT with healthy very preterm (VP) infants when they are 12 months of age (corrected age). The ACT has the potential to address the need for supporting emerging cognitive abilities of VP infants with an early intervention, which may capitalise on infants' neural plasticity.
METHODS/DESIGN METHODS
The feasibility study is designed to investigate whether it is possible to recruit and retain VP infants and their families in a randomised trial that compares attention and social attention of trained infants against those that are exposed to a control procedure. Feasibility issues include the referral/recruitment pathway, attendance, and engagement with testing and training sessions, completion of tasks, retention in the study, acceptability of outcome measures, quality of data collected (particularly, eye-tracking data). The results of the study will inform the development of a larger randomised trial.
DISCUSSION CONCLUSIONS
Several lines of evidence emphasise the need to support emerging cognitive and learning abilities of preterm infants using early interventions. However, early interventions with preterm infants, and particularly very preterm ones, face difficulties in recruiting and retaining participants. These problems are also augmented by the health vulnerability of this population. This feasibility study will provide the basis for informing the implementation of an early cognitive intervention for very preterm infants.
TRIAL REGISTRATION BACKGROUND
Registered Registration ID: NCT03896490. Retrospectively registered at Clinical Trials Protocol Registration and Results System (clinicaltrials.gov).

Identifiants

pubmed: 32055404
doi: 10.1186/s40814-020-0556-9
pii: 556
pmc: PMC7008548
doi:

Banques de données

ClinicalTrials.gov
['NCT03896490']

Types de publication

Journal Article

Langues

eng

Pagination

17

Informations de copyright

© The Author(s). 2020.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

Early Hum Dev. 2015 Feb;91(2):131-8
pubmed: 25617863
Res Dev Disabil. 2018 Mar;74:103-112
pubmed: 29413425
Early Hum Dev. 2007 Apr;83(4):247-54
pubmed: 16837146
Bull World Health Organ. 2010 Jan;88(1):31-8
pubmed: 20428351
Dev Med Child Neurol. 2003 Feb;45(2):97-103
pubmed: 12578235
Acta Paediatr. 2008 Jul;97(7):853-8
pubmed: 18482172
Dev Sci. 2011 Sep;14(5):1161-75
pubmed: 21884331
J Intellect Disabil Res. 2017 Nov;61(11):1034-1054
pubmed: 28699168
Acta Paediatr. 2015 Mar;104(3):e124-9
pubmed: 25382547
Trials. 2017 Sep 11;18(1):419
pubmed: 28889798
Child Neuropsychol. 2015;21(2):150-66
pubmed: 24511910
Pediatrics. 2009 Jun;123(6):1485-92
pubmed: 19482758
Epidemiology. 2015 Jan;26(1):106-11
pubmed: 25215531
J Child Psychol Psychiatry. 2016 Feb;57(2):132-40
pubmed: 26287264
Dev Neuropsychol. 2011;36(1):74-95
pubmed: 21253992
Clin Perinatol. 2018 Sep;45(3):393-408
pubmed: 30144845
Intelligence. 2009 May 1;37(3):311-320
pubmed: 20161244
Dev Med Child Neurol. 2013 Sep;55(9):788-96
pubmed: 23521214
Games Health J. 2018 Jun;7(3):175-181
pubmed: 29641289
Dev Med Child Neurol. 2018 Apr;60(4):342-355
pubmed: 29350401
Front Psychol. 2017 May 24;8:846
pubmed: 28596748
J Pers Assess. 2014;96(4):445-58
pubmed: 24206185
Rambam Maimonides Med J. 2013 Oct 29;4(4):e0025
pubmed: 24228168
Child Neuropsychol. 2002 Jun;8(2):71-82
pubmed: 12638061
Reprod Health. 2013;10 Suppl 1:S2
pubmed: 24625129
Pediatrics. 2018 Jan;141(1):
pubmed: 29255083
Curr Biol. 2011 Sep 27;21(18):1543-7
pubmed: 21889346
BMC Pediatr. 2013 Sep 16;13:144
pubmed: 24041245
PLoS One. 2013 May 24;8(5):e65219
pubmed: 23717694
Child Dev. 2018 May;89(3):e199-e213
pubmed: 28436545
Infant Behav Dev. 2018 Feb;50:180-188
pubmed: 29407427
Infant Behav Dev. 2008 Sep;31(3):333-51
pubmed: 18294695
Early Hum Dev. 2015 Dec;91(12):783-6
pubmed: 26443619
Psychol Assess. 2011 Jun;23(2):337-53
pubmed: 21480723
Intelligence. 2011 Jul;39(4):198-209
pubmed: 21643482
Ital J Pediatr. 2017 Oct 2;43(1):90
pubmed: 28969661
Child Dev. 1985 Aug;56(4):868-83
pubmed: 4042750
J Child Psychol Psychiatry. 2016 Jul;57(7):861-8
pubmed: 26934180
Pediatrics. 2009 Aug;124(2):717-28
pubmed: 19651588
Adv Child Dev Behav. 2006;34:283-322
pubmed: 17120808
Curr Biol. 2011 Sep 27;21(18):R684-5
pubmed: 21959152
JAMA Pediatr. 2018 Apr 1;172(4):361-367
pubmed: 29459939
J Dev Behav Pediatr. 2016 Jan;37(1):88-102
pubmed: 26703327
Dev Med Child Neurol. 2018 May;60(5):452-468
pubmed: 29453812
Early Hum Dev. 2009 Apr;85(4):225-30
pubmed: 19006652
Dev Psychol. 2003 May;39(3):563-71
pubmed: 12760523
J Int Neuropsychol Soc. 2007 Jul;13(4):571-81
pubmed: 17521479
Dev Med Child Neurol. 2005 Oct;47(10):653-9
pubmed: 16174307
J Clin Epidemiol. 2013 Feb;66(2):197-201
pubmed: 23195919
Dev Med Child Neurol. 2018 May;60(5):436
pubmed: 29468676
Ann Epidemiol. 2016 Apr;26(4):267-74
pubmed: 27085382
J Perinat Neonatal Nurs. 2017 Jul/Sep;31(3):244-255
pubmed: 28737545
Dev Psychol. 2017 May;53(5):815-825
pubmed: 28459273
Neuroimage. 2015 Feb 15;107:95-106
pubmed: 25498391
Dev Psychol. 2002 Nov;38(6):895-902
pubmed: 12428702
Chaos. 2011 Mar;21(1):013112
pubmed: 21456826
Early Hum Dev. 2014 Oct;90(10):639-44
pubmed: 25173650
Cochrane Database Syst Rev. 2015 Nov 24;(11):CD005495
pubmed: 26597166
J Dev Behav Pediatr. 2004 Dec;25(6):399-406
pubmed: 15613988
J Paediatr Child Health. 2011 Dec;47(12):863-9
pubmed: 21679332
Eur J Epidemiol. 2010 Sep;25(9):635-42
pubmed: 20532622

Auteurs

Oliver Perra (O)

1School of Nursing and Midwifery, Queen's University Belfast, Medical Biology Building, 97 Lisburn Road, Belfast, BT9 7BL Northern Ireland, UK.
2Centre for Evidence and Social Innovation, Queen's University Belfast, Belfast, Northern Ireland, UK.

Sam Wass (S)

3School of Psychology, University of East London, London, UK.

Alison McNulty (A)

TinyLife, The Premature Baby Charity for Northern Ireland, Belfast, UK.

David Sweet (D)

Health and Social Care Belfast Trust, Belfast, Northern Ireland, UK.

Kostas Papageorgiou (K)

6School of Psychology, Queen's University Belfast, Belfast, Northern Ireland, UK.

Matthew Johnston (M)

1School of Nursing and Midwifery, Queen's University Belfast, Medical Biology Building, 97 Lisburn Road, Belfast, BT9 7BL Northern Ireland, UK.
2Centre for Evidence and Social Innovation, Queen's University Belfast, Belfast, Northern Ireland, UK.
6School of Psychology, Queen's University Belfast, Belfast, Northern Ireland, UK.

Aaron Patterson (A)

6School of Psychology, Queen's University Belfast, Belfast, Northern Ireland, UK.

Delfina Bilello (D)

1School of Nursing and Midwifery, Queen's University Belfast, Medical Biology Building, 97 Lisburn Road, Belfast, BT9 7BL Northern Ireland, UK.
2Centre for Evidence and Social Innovation, Queen's University Belfast, Belfast, Northern Ireland, UK.
6School of Psychology, Queen's University Belfast, Belfast, Northern Ireland, UK.

Fiona Alderdice (F)

7Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Classifications MeSH